We are live on ! Find out more
MAM

Marquette Asset Management Portfolio holdings

AUM $779M
1-Year Est. Return 23.4%
This Fund
S&P 500
This Quarter Est. Return
+1.29%
1 Year Est. Return
+23.4%
3 Year Est. Return
+63.51%
5 Year Est. Return
+57.16%
10 Year Est. Return
+244.82%
AUM
$588M
AUM Growth
+$11.7M
Cap. Flow
+$6.55M
Cap. Flow %
1.11%
Top 10 Hldgs %
76.24%
Holding
211
New
14
Increased
34
Reduced
35
Closed
18

Sector Composition

Rank Sector Weight
1 Technology 1.14%
2 Consumer Discretionary 0.87%
3 Healthcare 0.62%
4 Communication Services 0.56%
5 Industrials 0.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BSCT icon
126
Invesco BulletShares 2029 Corporate Bond ETF
BSCT
$2.92B
$77K 0.01%
4,240
+55
+1% +$996
BSCS icon
127
Invesco BulletShares 2028 Corporate Bond ETF
BSCS
$3.57B
$76.6K 0.01%
3,840
+39
+1% +$777
BSCR icon
128
Invesco BulletShares 2027 Corporate Bond ETF
BSCR
$4.6B
$76.1K 0.01%
3,960
+40
+1% +$768
VEA icon
129
Vanguard FTSE Developed Markets ETF
VEA
$235B
$75.3K 0.01%
1,524
RFL icon
130
Rafael Holdings
RFL
$108M
$70.9K 0.01%
49,946
BSCQ icon
131
Invesco BulletShares 2026 Corporate Bond ETF
BSCQ
$3.64B
$69.2K 0.01%
3,609
+41
+1% +$786
BSCP
132
DELISTED
Invesco BulletShares 2025 Corporate Bond ETF
BSCP
$69.2K 0.01%
3,383
+37
+1% +$757
BSCO
133
DELISTED
Invesco BulletShares 2024 Corporate Bond ETF
BSCO
$68.6K 0.01%
3,256
PASG icon
134
Passage Bio
PASG
$15.1M
$67.9K 0.01%
4,275
HTLF
135
DELISTED
Heartland Financial USA, Inc.
HTLF
$65.7K 0.01%
1,479
SCHB icon
136
Schwab US Broad Market ETF
SCHB
$44.7B
$62.4K 0.01%
2,979
LUMO
137
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$59.8K 0.01%
25,760
KOD icon
138
Kodiak Sciences
KOD
$2.74B
$56.2K 0.01%
23,930
BIL icon
139
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$46.9B
$51.9K 0.01%
565
-757
-57% -$69.4K
IWN icon
140
iShares Russell 2000 Value ETF
IWN
$14.6B
$49.3K 0.01%
324
MCD icon
141
McDonald's
MCD
$194B
$45.9K 0.01%
180
VONV icon
142
Vanguard Russell 1000 Value ETF
VONV
$21.1B
$44K 0.01%
574
NUE icon
143
Nucor
NUE
$62.4B
$43.9K 0.01%
278
APG icon
144
APi Group
APG
$18.1B
$41.3K 0.01%
1,646
+11
+0.7% +$276
RSP icon
145
Invesco S&P 500 Equal Weight ETF
RSP
$99.5B
$34K 0.01%
207
IVV icon
146
iShares Core S&P 500 ETF
IVV
$901B
$33.9K 0.01%
62
-4
-6% -$2.1K
VOE icon
147
Vanguard Morningstar Mid-Cap Value ETF
VOE
$24B
$32.9K 0.01%
219
FLG
148
Flagstar Bank National Association
FLG
$5.99B
$32.2K 0.01%
3,333
DHR icon
149
Danaher
DHR
$140B
$31.5K 0.01%
126
AVDE icon
150
Avantis International Equity ETF
AVDE
$18.6B
$30.9K 0.01%
497

Similar funds

Marquette Asset Management's Q2 2024 Portfolio in Review

As of Q2 2024, Marquette Asset Management held 211 positions worth $588M, up 2% from $577M the previous quarter. Its ten largest holdings account for 76% of the portfolio.

Marquette Asset Management's Q2 2024 filing shows 14 new, 34 increased, 35 reduced and 18 closed positions. Its largest new stake was JPMorgan Equity Premium Income ETF: 292,060 shares worth $16.6M. The largest sale was State Street SPDR S&P Kensho New Economies Composite ETF, an estimated $26.7M.

By sector, the portfolio is most concentrated in Technology at 1.1% of assets, up from 1% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Marquette Asset Management's largest Q2 2024 buy was JPMorgan Equity Premium Income ETF: 292,060 shares worth $16.6M.
  • Marquette Asset Management added most to Schwab US Dividend Equity ETF in Q2 2024, an estimated $1.32M increase.
  • Marquette Asset Management's biggest Q2 2024 reduction was State Street SPDR S&P Kensho New Economies Composite ETF, cutting an estimated $26.7M.
  • Marquette Asset Management fully exited Overseas Shipholding Group Inc. in Q2 2024, selling an estimated $522K.
  • Marquette Asset Management's ten largest holdings make up 76% of its $588M portfolio in Q2 2024.
  • Marquette Asset Management opened 14 new positions and closed 18 in Q2 2024.
  • Marquette Asset Management's portfolio value rose 2% quarter-over-quarter to $588M.

Based on Marquette Asset Management's 13F filing for Q2 2024, filed 14 Aug 2024.